Investment

Woodford Investment Management has reportedly disposed of its stakes in IP Group and Allied Minds, as its scramble to meet regulatory thresholds and redemption demands from investors in its Equity Income fund gathers pace.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UC Berkeley's custom semiconductor spinout has now raised $125m, after Qualcomm Ventures joined existing investors such as Osage University Partners for a $65.4m series D round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Strand Therapeutics has raised seed funding to develop an mRNA engineering platform based on MIT research as it looks to assemble a pipeline of oncological drug candidates.

OncoMyx Therapeutics was co-founded by ASU's Grant McFadden and will use the series A funding to advance the development of its lead asset aimed at several indications of cancer.

With hundreds of university venture funds, internal commercialisation vehicles and third-party firms the reality in today’s innovation ecosystem, selecting the nominees and the winner for Investment Unit of the Year is increasingly challenging.

Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.